$AEYE

AudioEye, Inc. Hits New 52-Week Low at $6.11 Amidst Major Decline

AudioEye, Inc. has reached a new 52-week low of $6.11, marking a significant 70.6% drop in its stock price over the past year. The microcap company, with a market capitalization of $84 million, operates at a loss and has a high price-to-book ratio of 14.88, indicating potential overvaluation despite a recent increase in net sales. Its financial health is concerning due to decreasing profits and a reliance on debt financing.

Original reporting
Published Mar 15, 2026, 10:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 15, 2026, 11:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AudioEye, Inc. Hits New 52-Week Low at $6.11 Amidst Major Decline — source image
Decision brief

The 30-second read

$AEYEBearishLow
01

Why it matters

The recent price decline reflects investor concerns over financial health and growth prospects, which could lead to further selling pressure if negative fundamentals persist.

02

Market read

Given the company's small market cap and the bearish sentiment, the news has limited impact on broader markets but is highly relevant for microcap and technology sector traders.

03

What to watch

Possible upcoming catalysts such as restructuring, new product launches, or industry-wide recovery that could reverse the downward trend.

Timing: short-term (days to weeks)

Background

AudioEye, Inc. operates in the technology sector, providing accessibility solutions. The company has faced financial challenges, including operating losses and high valuation ratios, amid a broader downturn in microcap stocks.

Company-level read

Ticker impact

$AEYEBearishMedium confidence
Context

High relevance due to significant stock decline and bearish sentiment.

Expected impact

Potential further decline in the short term, with possible stabilization or rebound only if company fundamentals improve or positive catalysts emerge.

Evidence & confidence

The significant stock decline, combined with financial concerns and bearish sentiment, indicates a high probability of continued downward movement in the near term. However, the company's recent net sales increase and market overvaluation suggest potential for a rebound if fundamentals improve, hence medium confidence.

Market effects

The decline may negatively impact sentiment within the technology and financial markets sectors, especially among microcap stocks.

Limited regional impact due to the company's small market cap and localized trading activity.

Minimal; the company's size and market focus limit global influence.

Counterpoint

The stock's decline might represent an overreaction, presenting a potential buying opportunity for long-term investors willing to tolerate volatility.

Key entities

  • AudioEye, Inc.

    A microcap technology company specializing in digital accessibility solutions.

Related articles

$AEYEMed

AudioEye (AEYE) Q2 2026 Earnings Call Transcript

AudioEye reported Q2 2026 revenue of $10.7M, up 9% YoY, with adjusted EBITDA of $3M, a 54% increase. ARR reached $42.3M, up 11% sequentially. The company raised full-year adjusted EBITDA guidance to at least $12.7M and adjusted EPS to at least $0.98. Management highlighted growth in enterprise ARR and partner revenue, while noting risks from AI-driven accessibility issues and shifting legal risks to interior web pages.

$AEYEMed

Audioeye Q2 Earnings Call Highlights

AudioEye (NASDAQ:AEYE) reported Q2 net loss of $900,000, or $0.07/share, versus breakeven a year earlier, when a $1.4 million contingent consideration revaluation boosted results. Adjusted free cash flow was $2.6 million. Full-year adjusted EBITDA guidance rose to at least $12.7 million; revenue midpoint held at $43.5-$44.0 million. Q3 revenue forecast: $10.85-$11.05 million.

$AEYEHighAI 9/10

AudioEye Reports Record Second Quarter 2026 Results

AudioEye (Nasdaq: AEYE) reported Q2 2026 results for the quarter ended June 30, 2026. ARR rose to $42.3M from $41.2M sequentially and 11% YoY. Revenue increased 9% to $10.7M. Adjusted EBITDA was $3.0M. The company raised full-year adjusted EBITDA guidance and expects Q3 revenue $10.85M-$11.05M.

$AEYEMed

AUDIOEYE INC (AEYE): Results of Operations and Financial Condition

AUDIOEYE INC (AEYE) filed an SEC Form 8-K — Results of Operations and Financial Condition. ​ ​ Exhibit 99.1 ​ AudioEye Reports Record Second Quarter 2026 Results Forty-Second Consecutive Period of Record Revenue TUCSON, Ariz. — August 13, 2026 — AudioEye, Inc. (Nasdaq: AEYE) (“AudioEye” or the “Company”) , an industry-leading digital accessibility company, reported fin

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.